1. Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk
   Jason De Melo et al, 2015, PLOS ONE CrossRef
2. Genomic profile in gestational and non-gestational choriocarcinomas
   Julia Bette Homem de Mello et al, 2017, Placenta CrossRef
3. SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer’s Disease?
   Dhanya Krishnan et al, 2022, Cellular and Molecular Neurobiology CrossRef
4. SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer
   Juanjuan He et al, 2021, Frontiers in Oncology CrossRef
5. Shank‑associated RH domain interactor signaling in tumorigenesis (Review)
   Chong Zeng et al, 2020, Oncology Letters CrossRef
6. Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression
   Zelin Tian et al, 2019, Biomedicine & Pharmacotherapy CrossRef
7. SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel‐Lindau protein ubiquitination and degradation
   Rusha Yin et al, 2021, Cancer Science CrossRef
8. Next-Generation Cell Engineering Platform for Improving Recombinant Protein Production in Mammalian Cells
   Sung Wook Shin et al, 2021, Cell Culture Engineering and Technology CrossRef
9. SHARPIN S146 phosphorylation mediates ARP2/3 interaction, cancer cell invasion and metastasis
   Umar Butt et al, 2022, Journal of Cell Science CrossRef
10. SIRT4 regulates PTEN stability through IDE in response to cellular stresses
    Minghui Liu et al, 2019, The FASEB Journal CrossRef
11. Met1-linked ubiquitination in cell signaling regulation
    Yanmin Guo et al, 2024, Biophysics Reports CrossRef